The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
Eric Buckland of Translational Imaging Innovations and Ronald Schuchard, Clinical Product Development Expert, explore the benefits of ophthalmic precision medicine to improve patient care across sectors.
Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.
Rob Banathy, Senior Product Manager at NHS Digital, explains how his team developed a lateral flow device digital reader service that can detect nearly twice the number of positive COVID-19 cases during early infection compared to the human eye.
Long-term COVID-19 effects have been decreased from anywhere between 50 and 80% for those who have been vaccinated when compared to unvaccinated people.
Hospitals and trusts across the UK could be charged an additional £2 million per month for energy bills in the winter, due to national fuel costs surges.
Medical cannabis remains difficult to attain in healthcare under the British government, but it holds great promise for both NHS patients and the economy.
A healthcare data strategy is crucial to ensuring that we can tackle all the biggest health issues we face, and to ensure guided decision-making to save lives.
To ensure that new NHS technology does not overlook older patients, a survey has taken patient’s comfort levels of using digital services
Despite NHS technology...
Daryl Newsome FBDO R CL SMC(Tech), President of the Association of British Dispensing Opticians, examines the important role that optical practices can play in dealing with eye problems.
One in eight adults (12.7%) who are infected with SARS-CoV-2 experience long COVID symptoms, including chest pain, difficulties breathing, painful muscles and more.
Black patients and female patients with heart failure who qualify as candidates for surgery have a lower chance of getting that operation than white patients or male patients.
Relapse presents a major barrier to recovery from substance use disorders, and sleep disruptions have long been associated with drug withdrawal and relapse.
